BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chen CH, Bhasin S, Khanna P, Joshi M, Joslin PM, Saxena R, Amin S, Liu S, Sindhu S, Walker SR, Catalano P, Frank DA, Alper SL, Bhasin M, Bhatt RS. Study of Cathepsin B inhibition in VEGFR TKI treated human renal cell carcinoma xenografts. Oncogenesis 2019;8:15. [PMID: 30796200 DOI: 10.1038/s41389-019-0121-7] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
Number Citing Articles
1 Rudzinska-radecka M, Frolova AS, Balakireva AV, Gorokhovets NV, Pokrovsky VS, Sokolova DV, Korolev DO, Potoldykova NV, Vinarov AZ, Parodi A, Zamyatnin AA. In Silico, In Vitro, and Clinical Investigations of Cathepsin B and Stefin A mRNA Expression and a Correlation Analysis in Kidney Cancer. Cells 2022;11:1455. [DOI: 10.3390/cells11091455] [Reference Citation Analysis]
2 Tao L, Zhang H, An G, Lan H, Xu Y, Ge Y, Yao J. Balancing the Risk-Benefit Ratio of Immune Checkpoint Inhibitor and Anti-VEGF Combination Therapy in Renal Cell Carcinoma: A Systematic Review and Meta-Analysis. Front Oncol 2021;11:739263. [PMID: 34722290 DOI: 10.3389/fonc.2021.739263] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
3 Kim EK, Song MJ, Jang HH, Chung YS. Clinicopathologic Analysis of Cathepsin B as a Prognostic Marker of Thyroid Cancer. Int J Mol Sci 2020;21:E9537. [PMID: 33333840 DOI: 10.3390/ijms21249537] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
4 Kipper FC, Angolano C, Vissapragada R, Contreras MA, Moore J, Bhasin M, Ferran C, Thomas AJ. Embryonic periventricular endothelial cells demonstrate a unique pro-neurodevelopment and anti-inflammatory gene signature. Sci Rep 2020;10:20393. [PMID: 33230288 DOI: 10.1038/s41598-020-77297-3] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
5 Raimondo F, Pitto M. Prognostic significance of proteomics and multi-omics studies in renal carcinoma. Expert Rev Proteomics 2020;17:323-34. [PMID: 32428425 DOI: 10.1080/14789450.2020.1772058] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
6 Rudzińska M, Parodi A, Maslova VD, Efremov YM, Gorokhovets NV, Makarov VA, Popkov VA, Golovin AV, Zernii EY, Zamyatnin AA. Cysteine Cathepsins Inhibition Affects Their Expression and Human Renal Cancer Cell Phenotype. Cancers (Basel) 2020;12:E1310. [PMID: 32455715 DOI: 10.3390/cancers12051310] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
7 Lin CL, Hung TW, Ying TH, Lin CJ, Hsieh YH, Chen CM. Praeruptorin B Mitigates the Metastatic Ability of Human Renal Carcinoma Cells through Targeting CTSC and CTSV Expression. Int J Mol Sci 2020;21:E2919. [PMID: 32331211 DOI: 10.3390/ijms21082919] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]